Graves' Autoantibodies Exhibit Different Stimulating Activities in Cultures of Thyrocytes and Orbital Fibroblasts Not Reflected by Clinical Assays

• Published in: Thyroid (New York, N.Y.) Vol. 32; no. 1; p. 90
• Main Authors: Krieger, Christine C, Kahaly, George J, Azam, Asma, Klubo-Gwiezdzinska, Joanna, Neumann, Susanne, Gershengorn, Marvin C
• Format: Journal Article
• Language: English
• Published: United States 01.01.2022
• Subjects: Adult; Autoantibodies - analysis; Autoantibodies - immunology; Female; Fibroblasts - immunology; Fibroblasts - metabolism; Graves Disease - blood; Graves Disease - immunology; Graves Ophthalmopathy - blood; Graves Ophthalmopathy - complications; Graves Ophthalmopathy - pathology; Humans; Male; Middle Aged; Thyroid Epithelial Cells - immunology; Thyroid Epithelial Cells - metabolism; Thyrotropin - metabolism; Graves' disease; thyrotropin receptor stimulatory autoantibodies; thyroid stimulation; Graves' orbitopathy; orbital cell stimulation
• ISSN: 1557-9077
• DOI: 10.1089/thy.2021.0326

The pathogenesis of Graves' hyperthyroidism (GH) and associated Graves' orbitopathy (GO) appears to involve stimulatory autoantibodies (thyrotropin receptor [TSHR]-stimulating antibodies [TSAbs]) that bind to and activate TSHRs on thyrocytes and orbital fibroblasts. In general, measurement of circulating TSHR antibodies by clinical assays correlates with the status of GH and GO. However, most clinical measurements of TSHR antibodies use competitive binding assays that do not distinguish between TSAbs and antibodies that bind to but do not activate TSHRs. Moreover, clinical assays for TSAbs measure stimulation of only one signaling pathway, the cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) pathway, in engineered cells that are not thyrocytes or orbital fibroblasts. We determined whether measuring TSAbs by a cAMP-PKA readout in engineered cells accurately reveals the efficacies of stimulation by these antibodies on thyrocytes and orbital fibroblasts. We measured TSAb stimulation of normal human thyrocytes and orbital fibroblasts from patients with GO in primary cultures . In thyrocytes, we measured secretion of thyroglobulin (TG) and in orbital fibroblasts secretion of hyaluronan (hyaluronic acid [HA]). We also measured stimulation of cAMP production in engineered TSHR-expressing cells in an assay similar to clinical assays. Furthermore, we determined whether there were differences in stimulation of thyrocytes and orbital fibroblasts by TSAbs from patients with GH alone versus from patients with GO understanding that patients with GO have accompanying GH. We found a positive correlation between TSAb stimulation of cAMP production in engineered cells and TG secretion by thyrocytes as well as HA secretion by orbital fibroblasts. However, TSAbs from GH patients stimulated thyrocytes more effectively than TSAbs from GO patients, whereas TSAbs from GO patients were more effective in activating orbital fibroblasts than TSAbs from GH patients. Clinical assays of stimulation by TSAbs measuring activation of the cAMP-PKA pathway do correlate with stimulation of thyrocytes and orbital fibroblasts; however, they do not distinguish between TSAbs from GH and GO patients. , TSAbs exhibit selectivity in activating TSHRs since TSAbs from GO patients were more effective in stimulating orbital fibroblasts and TSAbs from GH patients were more effective in stimulating thyrocytes.